AIDX
HEALTHCARE20/20 Biolabs Inc
Live · NASDAQ · May 9, Close
What's Moving AIDX Today?
No stock-specific AI insight has been generated for AIDX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.39
Fundamentals
Trading
AIDX News
12 articles- HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor ConferenceYahoo Finance·Apr 13, 2026
- BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVYahoo Finance·Apr 10, 2026
- 20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia PlatformYahoo Finance·Apr 7, 2026
- 20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational ProgressGlobeNewswire Inc.·Mar 31, 2026
- Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood TestYahoo Finance·Mar 27, 2026
- 20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test ProgramYahoo Finance·Mar 24, 2026
- How The Healwell AI (TSX:AIDX) Investment Story Is Shifting With Recut Targets And Growth AssumptionsYahoo Finance·Mar 22, 2026
- HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes HoldYahoo Finance·Mar 19, 2026
- 20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent StudiesYahoo Finance·Mar 12, 2026
- 20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI CapabilitiesYahoo Finance·Feb 25, 2026
- 20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern TimeYahoo Finance·Feb 20, 2026
- 20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales GrowthYahoo Finance·Feb 19, 2026
All 12 articles loaded
Price Data
52-Week Range
$1.39
Fundamentals
Trading
About 20/20 Biolabs Inc
20/20 Biolabs, Inc. (ticker: AIDX) is a forward-thinking biotechnology company dedicated to advancing genomic research and diagnostics through innovative laboratory services. By focusing on improving the accuracy and efficiency of genetic testing for both clinical and research applications, the company is at the forefront of molecular diagnostics. With a strong commitment to harnessing cutting-edge technologies, 20/20 Biolabs is well-positioned to lead the charge in personalized medicine as the demand for genomic data accelerates. The company’s strategic initiatives and robust market positioning signal a promising growth trajectory in the dynamic biotechnology sector.